Keynote Presentation: Engineering of the Immune System

• Advancing Chimeric Antigen Receptor T-cell therapies: lessons learned from ex vivo engineered CAR T cell products
• Paving the way to in vivo generation of CAR-expressing immune cells: experience to date including viral and RNA-LNP based approaches
• The future of immunotherapy: bringing together precision medicine and nanotechnologies to advance safe, potent and tunable treatments for a broad range of disease categories

Speakers:

Xianghong Li

Managing Director & Ex-Senior Director, Head of Cell Engineering at Capstan

Bluepeak Partner